Literature DB >> 2861409

Can antigliadin antibody detect symptomless coeliac disease in children with short stature?

E Cacciari, S Salardi, U Volta, G Biasco, R Lazzari, G R Corazza, M Feliciani, A Cicognani, S Partesotti, D Azzaroni.   

Abstract

Duodenal biopsy and tests for antigliadin antibodies were done in 108 children with short stature unassociated with gastrointestinal symptoms. Other investigations for causes of growth failure were also carried out. In 88 patients, the cause of short stature could not be determined (group I). In 9 patients (8.3%) biopsy showed total villous atrophy, indicating probable coeliac disease (group II), while 7 patients had mild partial villous atrophy (group III). 4 patients (3.7%) had complete growth hormone deficiency. Antigliadin antibodies detected by immunofluorescence (IFL-AGA) were positive in 8 of the 9 group II patients. Symptomless coeliac disease is therefore a commoner cause of short stature than is hypopituitarism; by use of the IFL-AGA test it is possible to select patients for biopsy, thereby identifying most of the coeliac patients. If duodenal biopsies had been limited to IFL-AGA positive patients, 18 biopsies would have been carried out and coeliac disease would have been diagnosed in 8 of the 9 patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2861409     DOI: 10.1016/s0140-6736(85)92251-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  23 in total

Review 1.  Celiac disease: diagnostic criteria in progress.

Authors:  U Volta; V Villanacci
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

2.  Mucosal and systemic IgA anti-gliadin antibody in celiac disease. Contrasting patterns of response in serum, saliva, and intestinal secretions.

Authors:  C P Kelly; C F Feighery; R B Gallagher; M J Gibney; D G Weir
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

3.  Screening of diabetic children for coeliac disease with antigliadin antibodies and HLA typing.

Authors:  G Barera; C Bianchi; L Calisti; F Cerutti; F Dammacco; E Frezza; M T Illeni; L Mistura; M Pocecco; F Prisco
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

4.  New automated immunoassay measuring immunoglobulin A antigliadin antibodies for prediction of celiac disease in childhood.

Authors:  E Grodzinsky; A Ivarsson; P Juto; P Olcén; K Fälth-Magnusson; L A Persson ; O Hernell
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

5.  Growth hormone impaired secretion and antipituitary antibodies in patients with coeliac disease and poor catch-up growth after a long gluten-free diet period: a causal association?

Authors:  Lorenzo Iughetti; Annamaria De Bellis; Barbara Predieri; Antonio Bizzarro; Michele De Simone; Fiorella Balli; Antonio Bellastella; Sergio Bernasconi
Journal:  Eur J Pediatr       Date:  2006-08-03       Impact factor: 3.183

6.  Application of red cell distribution width to screening for coeliac disease in insulin-dependent diabetes mellitus.

Authors:  S D Johnston; C Ritchie; J Robinson
Journal:  Ir J Med Sci       Date:  1999 Jul-Sep       Impact factor: 1.568

7.  Effectiveness of antigliadin antibodies as a screening test for celiac disease in children.

Authors:  L J Chartrand; J Agulnik; T Vanounou; P A Russo; P Baehler; E G Seidman
Journal:  CMAJ       Date:  1997-09-01       Impact factor: 8.262

8.  Altered gastrointestinal immune response in sarcoidosis.

Authors:  P A McCormick; C Feighery; C Dolan; C O'Farrelly; P Kelliher; F Graeme-Cook; A Finch; K Ward; M X Fitzgerald; D P O'Donoghue
Journal:  Gut       Date:  1988-12       Impact factor: 23.059

9.  Coeliac disease in children of short stature without gastrointestinal symptoms.

Authors:  L Stenhammar; S P Fällström; G Jansson; U Jansson; T Lindberg
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

10.  Clinical utility of serologic testing for celiac disease in asymptomatic patients: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2011-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.